个人简介:

张明真,基础医学院特聘研究员/博士生导师,一附院特聘教授,医学工程研究所副所长,目前主要从事组织器官损伤修复及干预策略研究。在包括Nat Commun, J Am Chem Soc, Bioactive Materials, Nano Today, Mol Ther, Anal Chem等权威刊物上发表论文80余篇,入选ESI高被引论文10篇,论文引用4700余次,H指数34,申请发明专利10项;主持/参与国家自然科学基金、美国CCFA基金会基金、科技部重点研发计划、企业横向等项目10余项;担任Frontiers in Drug Delivery,现代生物技术研究副主编;Asian Journal of Pharmaceutical Sciences (IF: 10.2), Chinese Chemical Letters (IF: 9.1), Exploration, Pharmaceutical Science Advances, Journal of Analysis and Testing, Nano TransMed, Interdisciplinary Medicine等杂志青年编委;Nature Nanotechnology, Med, Advanced Materials, ACS nano等多个杂志评审专家;中国医学装备协会组织再生分会常务委员,中国抗癌协会肠病专业委员会委员,中国研究型医院学会细胞外囊泡研究与应用专业委员会(CSEV)委员,中国民族医药学会远程教育分会常务理事,陕西省抗癌协会整合肿瘤免疫治疗分会常委。

研究领域及方向:

以组织器官损伤修复(肠道、肝、肾、大脑等)为主要目标,在炎症、缺血、纤维化等不同病理状态下,探究组织器官损伤修复的有序调控与干预策略,主要包括:

1. 损伤修复障碍的病理基础及分子机制研究;

2. 中草药衍生囊泡及其应用;

3. 中草药衍生碳基纳米酶及其应用;

4. 中草药活性分子的靶向递送。

纳米中药与组织损伤修复调控

学习工作简历:

2009年09月-2014年06月:博士,华中科技大学;

2014年09月-2017年10月:博士后,美国佐治亚州立大学;

2017年11月-2018年03月:研究助理教授,美国佐治亚州立大学生物医学研究院;

2018年03月-至今:特聘研究员/博导,基础医学院。

科研项目:

主持/参与国家自然科学基金、美国CCFA基金会基金、国家重点研发计划、陕西省自然科学基金,企业横向等项目。

联系方式:

电话/微信:17765089956

电子邮箱:mzhang21@xjtu.edu.cn

联系地址:创新港21号楼

个人主页:http://gr.xjtu.edu.cn/web/mzhang21

代表性论文:

1. Zhang MZ* et al.Robust reactive oxygen species modulator hitchhiking yeast microcapsule for colitis alleviation by trilogically intestinal microenvironment renovation.Bioactive Materials. 2024.

2. Zhang MZ* et al.Platelet-inspired nanomedicine targeting activated neutrophils to alleviate ulcerative colitis by free radicals scavenging and controlled neutrophil swarming.Nano Today. 2024, 54: 102139.

3. Zhang MZ* et al.Carbon dots enhanced peroxidase-like activity of platinum nanozyme.Nanoscale. 2024, 16: 4637-4646.

4. Zhang MZ* et al.Deciphering the catalytic mechanism of superior superoxide dismutase activity of carbon dot nanozyme.Nature Communications.2023, 14: 160.

5. Zhang MZ* et al.Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics.Carbon. 2023, 204: 526-537.

6. Zhang MZ* et al.Integrating Pt nanoparticles with carbon nanodots to achieve robust cascade superoxide dismutase-catalase nanozyme for antioxidant therapy.Nano Today. 2023, 49: 101768.

7. Zhang MZ* et al.Reactive Oxygen Species-Responsive Nanocarrier Ameliorates Murine Colitisby Intervening Colonic Innate and Adaptive Immune Responses.Molecular Therapy. 2023, 31(5):1383-1401.

8. Zhang MZ* et al.A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage.Nano Today. 2023, 49: 101798.

9. Zhang MZ* et al.Oral delivery of therapeutic andrographolide/carbon monoxide (CO) donor for synergistic treatment of ulcerative colitis by anti-inflammation and pro-resolution.ACS Applied Materials & Interfaces. 202315, 30, 36061–36075.

10. Zhang MZ* et al.Biomimetic nanoreactors for combinational chemo/chemodynamic therapy of choriocarcinoma through synergistic apoptosis and ferroptosis strategy.Chemical Engineering Journal. 2023, 472: 144690.

11. Zhang MZ* et al.Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer.Chemical Engineering Journal. 2023, 472: 144911.

12. Zhang MZ* et al.Immune adjuvant functionalized biomimetic nanocarriers combine sonodynamic therapy for enhanced cancer immunotherapy.Chemical Engineering Journal. 2023, 476: 145685.

13. Zhang MZ* et al.Biosensing intestinal alkaline phosphatase by pregnancy test strips based on target-triggered CRISPR-Cas12a activity to monitor intestinal inflammation.Analytical Chemistry.2023, 95(37): 14111–14118.

14. Zhang MZ* et al.Metal polyphenol network/cerium oxide artificial enzymes therapeutic nanoplatform for MRI/CT imaging-aided intestinal inflammation management.Nano Today. 2023, 53: 102044.

15. Zhang MZ* et al.Macrophage-biomimetic liposomes delivery of carbon dots nanozymes ameliorate ulcerative colitis by modulating inflammation pathways and remodeling the redox microenvironment.Chemical Engineering Journal. 2023, 477: 146796.

16. Zhang MZ* et al.Carbon dot nanozymes as free radicals scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosis.Journal of Nanobiotechnology.2023, 21:500.

17. Zhang MZ* et al.Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.Journal of Nanobiotechnology. 2023, 21: 21.

18. Zhang MZ* et al.Point-of-care monitoring of dry eye disease using lysozyme in tear based on commercial pregnancy test strips.Sensors and Actuators B-Chemical. 2023, 378: 133179.

19. Zhang MZ* et al.Plant-derived vesicle-like nanoparticles: clinical application exploration and challenges.International Journal of Nanomedicine.2023, 18: 5671-5683.